FDA Inspection
Zhejiang Huahai PharmaceuticalZhejiang Huahai Pharmaceutical – FDA Inspection, Nov 20, 2024
Record Details
This FDA Inspection record concerns Zhejiang Huahai Pharmaceutical, with an inspection on November 20, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 07e8ffd9-9d11-4463-b53d-85f4ca55830c
Inspection Facts
- Inspection number
- 1255905
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Huahai Pharmaceutical
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 29, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 3, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 19, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 23, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Huahai Pharmaceutical
- FDA Inspection 1150702 - 2021-07-29
- FDA Inspection 1062283 - 2018-08-03
- FDA Inspection 1012805 - 2017-05-19
- FDA Inspection 886530 - 2014-05-23
- FDA Inspection 712157 - 2010-09-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.